Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The malignant phenotype is largely the consequence of dysregulated gene expression. Transformed cells depend upon not just a global increase in protein synthesis but an altered translational landscape in which pro-oncogenic mRNAs are translationally up-regulated. Such mRNAs have been shown to possess longer and more structured 5′-UTRs requiring high levels of eukaryotic initiation factor 4A (eIF4A) helicase activity for efficient translation. As such there is a developing focus on targeting eIF4A as a cancer therapy. In order for such treatments to be successful, we must develop a detailed understanding of the mechanisms which make specific mRNAs more dependent on eIF4A activity than others. It is also crucial to fully characterize the potentially distinct roles of eIF4A1 and eIF4A2, which until recently were thought to be functionally interchangeable. This review will highlight the recent advances made in this field that address these issues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The RNA helicase eIF4A unwinds the complex 5′ UTR structures of cap-dependent transcripts and is a critical component of the eIF4F translational complex (10, 17).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [17]
Citations
Cites
Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206928 · Cited by 2,189
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation
Kumari, S., Bugaut, A., Huppert, J. L., & Balasubramanian, S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio864 · Cited by 822
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
The Scanning Mechanism of Eukaryotic Translation Initiation
Hinnebusch, A. G. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035802 · Cited by 798
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
5'-UTR RNA G-quadruplexes: translation regulation and targeting
Bugaut, A., & Balasubramanian, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks068 · Cited by 642
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635
Pestova, T. V., & Kolupaeva, V. G. (2002) · Genes & Development · doi:10.1101/gad.1020902 · Cited by 566
Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 434
Cited by
Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
Mohibi, S., Chen, X., & Zhang, J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.001 · Cited by 199
Aptamers: Uptake mechanisms and intracellular applications
Yoon, S., & Rossi, J. J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.003 · Cited by 169
Tailor made: the art of therapeutic mRNA design
Metkar, M., Pepin, C. S., & Moore, M. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00827-x · Cited by 178
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Cai, W., Chen, Z. X., Rane, G., Singh, S. S., Choo, Z., Wang, C., Yuan, Y., Tan, T. Z., Arfuso, F., Yap, C. T., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw278 · Cited by 119
Wilczynska, A., Gillen, S. L., Schmidt, T., Meijer, H. A., Jukes-Jones, R., Langlais, C., Kopra, K., Lu, W.-T., Godfrey, J. D., Hawley, B. R., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1857-2 · Cited by 62
Self-citationExpression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers
Xue, C., Gu, X., Li, G., Bao, Z., & Li, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711965 · Cited by 60
DEAD-Box RNA Helicases in Cell Cycle Control and Clinical Therapy
Zhang, L., & Li, X. (2021) · Cells · doi:10.3390/cells10061540 · Cited by 53
Xia, T., Dai, X., Sang, M., Zhang, X., Xu, F., Wu, J., Shi, L., Wei, J., & Ding, Q. (2024) · Advanced Science · doi:10.1002/advs.202305142 · Cited by 52
Rahman, M. M., Bagdassarian, E., Ali, M. A. M., & McFadden, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-15941-1 · Cited by 52
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Sridharan, S., Robeson, M., Tukaramrao, D. B., Howard, C. M., Subramaniyan, B., Tilley, A. M. C., Tiwari, A. K., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01311 · Cited by 55
Zhao, Y., Wang, Y., Chen, W., Bai, S., Wang, P., Zheng, M., Yang, Y., Cheng, B., & Luan, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02390-0 · Cited by 48
Waldron, J. A., Raza, F., & Quesne, J. P. C. L. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky108 · Cited by 45
Self-citationAli, M. A. M. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01892-1 · Cited by 48
Gao, C., Guo, X., Xue, A., Ruan, Y., Wang, H., & Gao, X. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz168 · Cited by 42
DEAD-box helicase eIF4A2 inhibits CNOT7 deadenylation activity
Meijer, H. A., Schmidt, T., Gillen, S. L., Langlais, C., Jukes‐Jones, R., de Moor, C. H., Cain, K., Wilczynska, A., & Bushell, M. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz509 · Cited by 45
Schmidt, T., Dąbrowska, A., Waldron, J. A., Hodge, K., Koulouras, G., Gabrielsen, M., Munro, J., Tack, D. C., Harris, G., McGhee, E. J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad030 · Cited by 41
Self-citationTargeting Protein Synthesis in Colorectal Cancer
Schmidt, S., Denk, S., & Wiegering, A. (2020) · Cancers · doi:10.3390/cancers12051298 · Cited by 38
RNA G-Quadruplexes as Key Motifs of the Transcriptome
Rouleau, S. G., Jodoin, R., Garant, J., & Perreault, J. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_8 · Cited by 38
Action and function of helicases on RNA G-quadruplexes
Caterino, M., & Paeschke, K. (2021) · Methods · doi:10.1016/j.ymeth.2021.09.003 · Cited by 34
Chen, L., Miao, Y., Liu, M., Zeng, Y., Gao, Z., Peng, D., Hu, B., Xu, L., Zheng, Y., Xue, Y., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00254 · Cited by 32
Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents
Fan, A. P., & Sharp, P. P. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01746 · Cited by 31
Wu, C., Liu, D., Zhang, L., Wang, J., Ding, Y., Sun, Z., & Wang, W. (2023) · Frontiers of Medicine · doi:10.1007/s11684-022-0966-6 · Cited by 34
Howard, C. M., Bearss, N. R., Subramaniyan, B., Tilley, A. M. C., Sridharan, S., Villa, N., Fraser, C. S., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00284 · Cited by 27
Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
Kayastha, F. B., Herrington, N. B., Kapadia, B. B., Roychowdhury, A., Nanaji, N. M., Kellogg, G. E., & Gartenhaus, R. B. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00534-0 · Cited by 26
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Nardi, F., Perurena, N., Schade, A. E., Li, Z.-H., Ngo, K., Ivanova, E. V., Saldanha, A., Li, C., Gokhale, P. C., Hata, A. N., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167651 · Cited by 21
“A key component of the eIF4F complex is the RNA helicase eIF4A, which is required to unwind the secondary structures of cap-dependent transcripts (10, 17).”
Popławski, P., Wiśniewski, J. R., Rijntjes, E., Richards, K. H., Rybicka, B., Köhrle, J., & Piekiełko‐Witkowska, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190179 · Cited by 21
Yu, W., Liang, J., Fang, T., Jiang, J., Zhao, R., Li, R., Han, J., & Tian, H. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0984 · Cited by 19
Translation initiation and its relevance in colorectal cancer
Minnee, E., & Faller, W. J. (2020) · FEBS Journal · doi:10.1111/febs.15690 · Cited by 21
Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential
Digregorio, M., Lombard, A., Lumapat, P. N., Felix, S., Rogister, B., & Coppieters, N. (2019) · Cells · doi:10.3390/cells8121542 · Cited by 15
Xu, Y., Jiang, Q., Liu, H., Xiao, X., Yang, D., Saw, P. E., & Luo, B. (2020) · Journal of Immunology Research · doi:10.1155/2020/8835393 · Cited by 14
Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action
Zerio, C. J., Cunningham, T. A., Tulino, A. S., Alimusa, E. A., Buckley, T. M., Moore, K. T., Dodson, M. B., Wilson, N. C., Ambrose, A. J., Shi, T., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01014 · Cited by 11
Lindberg, J. H., Widgren, A., Ivansson, E. L., Gustavsson, I. M., Stålberg, K., Gyllensten, U. B., Sundfeldt, K., Bergquist, J., & Enroth, S. (2024) · iScience · doi:10.1016/j.isci.2024.109001 · Cited by 10
Unveiling the translational dynamics of lychee (Litchi chinesis Sonn.) in response to cold stress
Chen, M., Dai, S., Chen, D., Chen, H., Feng, N., & Zheng, D. (2024) · BMC Genomics · doi:10.1186/s12864-024-10591-w · Cited by 8
Programmed cell death 4 mechanism of action: The model to be updated?
Вихрева, П. Н., Калиниченко, С. В., & Korobko, I. V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1371881 · Cited by 9
Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets
Sehrawat, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910835 · Cited by 8
Essegian, D. J., Cunningham, T. A., Zerio, C. J., Chapman, E., Schatz, J. H., & Schürer, S. C. (2021) · ACS Omega · doi:10.1021/acsomega.1c02805 · Cited by 7
Wu, K., Huang, Y., Wu, Y., Chang, C., Chang, Y.-Y., Chiang, H., Liu, L.-X., Tsai, Y., & Hung, J. (2022) · Biology · doi:10.3390/biology11070975 · Cited by 7
Patel, K., Vora, H., & Patel, P. S. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.2.371 · Cited by 5
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma
Safari, M., Scotto, L., Basseville, A., Litman, T., Xue, H., Petrukhin, L., Zhou, P., Remotti, H. E., Ku, A. W., Morales, D. V., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101312 · Cited by 8
Connelly, J. A., Mody, R. J., Wu, Y., Robinson, D. R., Lonigro, R. J., Vats, P., Rabban, E., Anderson, B., & Walkovich, K. J. (2018) · Molecular Case Studies · doi:10.1101/mcs.a002204 · Cited by 4
Zheng, Y., Peng, W., Wen, X.-P., & Wan, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32579 · Cited by 3
Hardy, J. G., Tellier, M., Murphy, S., & Norbury, C. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/177980 · Cited by 3
Structural Basis for the Improved RNA Clamping of Amidino-Rocaglates to eIF4A1
Conley, J. F., Brown, L. E., McNeely, J. H., Pelletier, J., Porco, J. A. J., & Allen, K. N. (2025) · ACS Omega · doi:10.1021/acsomega.4c09421 · Cited by 2
Liu, M., Zhang, L., & Yan, Z. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2501.01010 · Cited by 2
Zhu, X., Jia, L., Kuai, X., Tang, Q., Chang, X., Zhang, X., Chen, B., Zhi, H., Hu, H., Huang, X., et al. (2025) · Oncology Reports · doi:10.3892/or.2025.8951 · Cited by 3
G-Quadruplex Resolving by Specific Helicases
Schult, P., Simon, P., & Paeschke, K. (2023) · Springer eBooks · doi:10.1007/978-981-16-1313-5_101-1 · Cited by 3
EIF4A3-Induced hsa_circ_0118578 Expression Enhances the Tumorigenesis of Papillary Thyroid Cancer
Li, C., Xie, P., Luo, M., Lv, K., & Cong, Z. (2024) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2024.0133 · Cited by 2
Chao, Y. L., Zhu, Y., Wiedner, H. J., Tsai, Y., Wilkinson, L., Porrello, A., Swearingen, A. E. D. V., Carey, L., Giudice, J., Holley, C. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.272617 · Cited by 2
eIF4A1 is essential for reprogramming the translational landscape of Wnt-driven colorectal cancersPreprint
Waldron, J. A., Kanellos, G., Smith, R. C. L., Knight, J. R. P., Munro, J., Alexandrou, C., Vlahov, N., Pardo, L., Moore, M. H., Gillen, S. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.10.566546 · Cited by 2
Self-citationTang, B., Wang, L., Wei, D., Wang, T., Zou, R., Su, K., Wu, T., Cun, D., & Wang, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-03393-3 · Cited by 1
G-Quadruplex Resolving by Specific Helicases
Schult, P., Simon, P., & Paeschke, K. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_101 · Cited by 1
Schmidt, T., Dąbrowska, A., Waldron, J. A., Hodge, K., Koulouras, G., Gabrielsen, M., Munro, J., Tack, D. C., Harris, G., McGhee, E. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.08.503179 · Cited by 1
Self-citationAssessment of Single Nucleotide Variants in hGPRC5A Gene Using in-silico ToolsPreprint
Karaali, M. D., Uz, E., & Çelikler, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3576134/v1 · Cited by 1
Zhao, Y., Wang, Y., Chen, W., Bai, S., Wang, P., Zheng, M., Yang, Y., Cheng, B., & Luan, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-907935/v1
The role of SRSF6 in the alternative splicing response to hypoxia
Stahl, C. F. (2020) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.70296
Rosenfeld, P., Singh, G., Herrera, A. P., Ji, J., Seufzer, B. J., Heng, X., Boris‐Lawrie, K., & Cochrane, A. (2024) · Viruses · doi:10.3390/v16091506
BLF1 Affects ATP Hydrolysis Catalyzed by Native and Mutated eIF4A1 and eIF4A2 Proteins
An, M. J., Cheng, X., Zhang, Y., Gu, J., & Mao, X. (2025) · Toxins · doi:10.3390/toxins17050232
Additional file 1 of Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
Kayastha, F. B., Herrington, N. B., Kapadia, B. B., Roychowdhury, A., Nanaji, N. M., Kellogg, G. E., & Gartenhaus, R. B. (2022) · Figshare · doi:10.6084/m9.figshare.20921226
Chen, M., Dai, S., Chen, D., Chen, H., Naijie, F., & Zheng, D. (2024) · Figshare · doi:10.6084/m9.figshare.26748416
Enhancement of Therapeutic mRNA Translation in Cellular Stress Conditions
Trepkowska-Mejer, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114663
Apoptosis and Autophagy Modulators in Cancer Therapeutics
Patel, V., Islam, M. S., & Kotnis, A. L. (2026) · Springer eBooks · doi:10.1007/978-981-92-0477-9_21
BindingDB Entry 50018392: Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents.
BindingDB (2024) · UC San Diego · doi:10.7270/q2t43z96
BindingDB Entry 50018671: Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action.
BindingDB (2024) · UC San Diego · doi:10.7270/q22j6h3k
Metadata
- Authors
- Raza, F., Waldron, J. A., & Quesne, J. L.
- Affiliations
- Medical Research Council (GB)
- Medical Research Council Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, U.K.
- Corresponding author
- Raza, Farheen
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2015-11-27
- Volume
- 43
- Issue
- 6
- Pages
- 1227-1233
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2179151406
- Cited by
- 61
- References
- 60
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 10 · 2022: 4 · 2021: 10 · 2020: 6 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 1
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Society Transactions (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- eIF4A, eIF4A1, EIF4A2, translation initiation
- MeSH terms
- Benzofurans, Epoxy Compounds, Humans, Neoplasms, Sterols, Thiazoles, Protein Biosynthesis, Triterpenes, Gene Expression Regulation, Neoplastic, Macrolides, Protein Isoforms, Eukaryotic Initiation Factor-4A, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.